Promising Chinese candidate vaccines containing adjuvants provided by US and UK firms have delivered positive trial data, demonstrating their safety and efficacy against Covid-19.
On Friday, China’s biopharmaceuticals firm Clover claimed data from human trials showed their two candidate vaccines triggered a “strong immune response” against Covid-19.
Continue reading https://on.rt.com/awht